Complex Lipid Management Program Self-Assessment Program Series
|
| Release Date: | June 15, 2009 |
| Last Update: | June 15, 2009 |
| Expiration Date: | June 15, 2011 |
Program Overview
You are invited to participate in the Complex Lipid Management Self-Assessment Program (CLM-SAPTM) Series Edition 11 - Clinical Applications Of Lipoprotein Subfractionation Testing, Inflammatory Markers And Non-Invasive Assessments Of Atherosclerosis. Edition 11 of CLM-SAP is part of a series designed to help you strengthen and reinforce your knowledge of clinical lipidology. Through a guided assessment exam process, the programs are designed to uncover gaps in knowledge that will motivate self-directed professionals to take action to close it.
The CLM-SAP and NLA-SSM modules were developed utilizing medical board certifying examination principles to provide an active learning experience that will improve your understanding of the options available for managing patients with lipid disorders. Each SAP module is comprised of a syllabus and an assessment with 90+ multiple-choice questions. Upon completion of the assessment questions, you will access detailed explanations (referred to as "Educational Critiques") and references to other educational resources. The multiple-choice questions are challenging and designed to reinforce educational concepts that are expanded upon in the Critiques. The Syllabus, Assessment and Educational Critiques together provide a complete learning experience.
The credits earned by completing the SAP modules can be applied toward meeting the requirements necessary to be eligible for the American Board of Clinical Lipidology (ABCL) and the Accreditation Council for Clinical Lipidology (ACCL) Certifying Examinations.
Learning Objectives
Target Audience
Lipidologists and Clinical Lipid Specialists, as well as Cardiologists, Endocrinologists, Nephrologists, Primary Care Physicians, General Internists, Family Practitioners, Cardiovascular Nurses, Physician Assistants, Pharmacists, and Dietitians involved in lipid management.
Accreditation
The estimated time for completion of this activity is 6 hours. This CME activity was planned and produced in accordance with ACCME Standards.
CME credit provided by the National Lipid Association
Physicians
The National Lipid Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The National Lipid Association designates this educational activity for a maximum of 6 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CE credit provided by the Institute for Continuing Healthcare Education
Nurses
1 Contact Hour = 60 minutes
The Institute for Continuing Healthcare Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity offers 6 contact hours to participating nurses. This credit may be applied toward licensure requirements in those states that recognize American Nurses Credentialing Center's Commission on Accreditation (ANCC-COA) accredited providers.
Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.
California Nurses
The Institute for Continuing Healthcare Education is approved by the California Board of Registered Nursing, Provider Number 13313. The Institute for Continuing Healthcare Education approves this activity for 7 contact hours.
Jacqueline A. Dawson, MSN, RN is the nurse planner for this activity. She is a subcontractor for the Institute for
Continuing Healthcare Education. She has no other financial relationships to disclose.
It is important to note that this educational activity is offered in two alternate formats. Participants may only apply for contact hours upon completion of one of the formats. Awarding of contact hours for multiple formats of the same education is prohibited.
Dietitians
This program is cosponsored by the Institute for Continuing Healthcare Education and the National Lipid Association. The Institute for Continuing Healthcare Education, provider number IN003 is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR) from March 28, 2007 to March 27, 2010. Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 5 continuing professional education units (CPEUs) for completion of this Level 2 program. Continuing Professional Education Provider Accreditation does not constitute endorsement by the CDR of a provider, program, or materials.
It is important to note that this educational activity is offered in two alternate formats. Participants may only apply for CPEUs upon completion of one of the formats. Awarding of CPEUs for multiple formats of the same education is prohibited.
Instructions for Completing CLM-SAP and NLA-SSM Online Modules
Fee
NLA members: There is no fee for this activity. Non-Members: There is a fee of $80 to participate in this activity.
Commercial Support
The print and online versions of this activity have been supported by educational grants from Atherotech, Berkeley HeartLab, Inc., DiaDexus, LipoScience and Merck & Co., Inc. It is the policy of the NLA to adhere to ACCME Essential Areas, Policies and Standards for Commercial Support in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs.
Program Faculty
Chair
Michael H. Davidson, MD, FACC, FACP, FNLA
Diplomate, American Board of Clinical Lipidology
Clinical Professor
Director of Preventive Cardiology
Pritzker School of Medicine
The University of Chicago
Executive Medical Director
Radiant Research
Chicago, IL
Faculty
M. Dominique Ashen, Ph.D., CRNP
The Johns Hopkins Ciccarone Center
for the Prevention of Heart Disease
Baltimore,MD
Seth J. Baum, MD, FACC, FNLA
Diplomate, American Board of Clinical Lipidology
Co-Director of Cardiac CT
Preventive Cardiologist
South Florida Medical Imaging
Boca Raton, FL
Vera Bittner, MD, FACC, FNLA
Diplomate, American Board of Clinical Lipidology
Professor of Medicine
Section Head
Preventive Cardiology
University of Alabama at Birmingham
Birmingham,AL
Roger Blumenthal, MD,FACC, FNLA
Professor of Medicine
Director, The Johns Hopkins Ciccarone Center
for the Prevention of Heart Disease
Baltimore,MD
Chief Editor
Dante S. LaRocca, Ph.D
President
Professional Evaluation, Inc.
Ambler, PA
Editorial Review Board
Carl Orringer, MD, FACC, FNLA
Diplomate, American Board of Clinical Lipidology
Associate Professor of Medicine
Case Western Reserve
School of Medicine
Cleveland, OH
National Lipid Association Disclosure Policy
In accordance with the ACCME Standards for Commercial Support and the policy of the NLA, any faculty relationship with the manufacturer(s) of any commercial product(s) discussed in this educational activity, which in the context of their presentation could be perceived as a real or apparent conflict of interest (e.g., ownership of stock, honoraria, research grants, or consulting fees), is disclosed below.
Unapproved Uses of Drugs/Devices
In accordance with requirements of the FDA, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA approved package insert for each drug/device for full prescribing/utilization information.
Michael H. Davidson, M.D.
Consultant; Grant/Research Support; Honorarium; Speakers' Bureau: Abbott Laboratories, AstraZeneca,
Bristol-Myers Squibb, Merck & Co. Inc., Merck/Schering-Plough, Novartis; Pfizer Inc., Reliant Pharmaceuticals,
Sankyo, Sumitomo, Takeda North America; Stockholder: None.
M. Dominique Ashen, Ph.D.
None
Seth J. Baum, M.D.
Consultant/Speakers' Bureau: LipoScience, Schering-Plough; Stockholder: None.
Vera Bittner, M.D., FACC
Consultant/Research Support: Abbott Laboratories, Atherogenics, CV Therapeutics, Merck & Co. Inc, Novartis,
Pfizer Inc., Reliant Pharmaceuticals; Stockholder: None.
Roger Blumenthal, M.D.
Research Support: Merck & Co. Inc., Pfizer Inc.,; Stockholder: None.
Dante S. LaRocca, Ph.D.
None
Carl Orringer, M.D.
Speakers' Bureau: Abbott, Merck & Co. Inc., Pfizer, Reliant, Schering-Plough; Stockholder: None.
Disclaimer
The opinions or views expressed in this publication are those of the program faculty and do not necessarily reflect the opinions or recommendations of the National Lipid Association or the commercial supporter(s).
The faculty may have included discussion on unlabeled uses of a commercial product or an investigational use of a product not yet approved for this purpose. Please consult the full prescribing information before using any medication mentioned in this publication.
Viewing Requirements:
This program requires the AdobeTM Flash Plugin. In most cases, you will already have this plugin installed. If you do not have it installed or an update is required, this should happen automatically. For problems with AdobeTM Flash, please visit the AdobeTM Flash Website.
This program works best in Firefox 3.0 or higher or Internet Explorer 7.0 or higher, however, earlier versions of both browsers are supported. In most cases, a free browser upgrade will address any issues you may experience with this program.
Portions of this program will need to popup a new browser window. You should disable any popup blocking software for the duration of your participation in this activity.
This program will need to place files on your hard drive called "cookies." Cookies enable the program to keep track of your responses, remember your place in the program and identify you if you choose to complete this activity across multiple sessions. You must have cookies enabled in your web browser for this program to function correctly. In most cases, this will be the default.
NLA Members can take this program for free. Just login using the box at top right of any NLA page or JOIN.
An NLA Non-Member purchase option will be available in early August.
